Overview

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether dutasteride may influence the expression of angiogenesis factors such as hypoxia inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF) in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH).
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
GlaxoSmithKline
The Korean Urological Association
Treatments:
Dutasteride